{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:44Z","timestamp":1792096364810,"version":"4.4.0"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The in vitro sensitivities of 30 strains of\n            <jats:italic>Nocardia brasiliensis<\/jats:italic>\n            to DA-7867, gatifloxacin, moxifloxacin, and BMS-284756 (garenoxacin) were determined using the broth microdilution method. All\n            <jats:italic>N. brasiliensis<\/jats:italic>\n            strains were sensitive to these antimicrobials. The most active drug in vitro was DA-7867, with a MIC at which 90% of the isolates tested were inhibited of 0.03 \u03bcg\/ml and a MIC at which 50% of the isolates tested were inhibited of 0.06 \u03bcg\/ml.\n          <\/jats:p>","DOI":"10.1128\/aac.48.2.602-604.2004","type":"journal-article","created":{"date-parts":[[2004,1,24]],"date-time":"2004-01-24T23:46:39Z","timestamp":1074987999000},"page":"602-604","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["In Vitro Activities of New Antimicrobials against\n            <i>Nocardia brasiliensis<\/i>"],"prefix":"10.1128","volume":"48","author":[{"given":"Lucio","family":"Vera-Cabrera","sequence":"first","affiliation":[{"name":"Laboratorio Interdisciplinario de Investigacio\u0301n Dermatolo\u0301gica, Servicio de Dermatologi\u0301a, Hospital Universitario, Monterrey, Nuevo Leo\u0301n, Me\u0301xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Laboratorio Interdisciplinario de Investigacio\u0301n Dermatolo\u0301gica, Servicio de Dermatologi\u0301a, Hospital Universitario, Monterrey, Nuevo Leo\u0301n, Me\u0301xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung H.","family":"Choi","sequence":"additional","affiliation":[{"name":"Research Lab., Dong-A Pharm. Co., Ltd., Yongin, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliverio","family":"Welsh","sequence":"additional","affiliation":[{"name":"Laboratorio Interdisciplinario de Investigacio\u0301n Dermatolo\u0301gica, Servicio de Dermatologi\u0301a, Hospital Universitario, Monterrey, Nuevo Leo\u0301n, Me\u0301xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1295-1297.2001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00007"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059010-00002"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.6.891"},{"key":"e_1_3_2_6_2","first-page":"477","volume":"128","year":"1992","unstructured":"L\u00f3pez-Mart\u00ednez, R., L. J. M\u00e9ndez-Tovar, P. Lavalle, O. Welsh, A. Saul, and E. Macotela-Ru\u00edz. 1992. Epidemiolog\u00eda del micetoma en M\u00e9xico: estudio de 2105 casos. Gac. Med. Mex.128:477-481.","journal-title":"Gac. Med. Mex."},{"key":"e_1_3_2_7_2","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. Document M7-A4. National Committee for Clinical Laboratory Standards Villanova Pa."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/345907"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.8.2059"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jac\/dkf081","volume":"50","year":"2002","unstructured":"Valera, L., E. Gradelski, E. Huczko, T. Washo, H. Yigit, and J. Fung-Tomc. 2002. In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates. J. Antimicrob Chemother.50:140-142.","journal-title":"J. Antimicrob Chemother."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3629-3630.2001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.1.177"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(87)70227-8","volume":"17","year":"1987","unstructured":"Welsh, O., E. Sauceda, J. Gonz\u00e1lez, and J. Ocampo. 1987. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J. Am. Acad. Dermatol.17:443-448.","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-4362.1991.tb03892.x","volume":"30","year":"1991","unstructured":"Welsh, O. 1991. Mycetoma: current concepts in treatment. Int. J. Dermatol.30:387-398.","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_2_15_2","unstructured":"Welsh O. M. C. Salinas and M. A. Rodr\u00edguez. 1994. Mycetoma p. 1402-1406. In P. D. Hoeprich M. C. Jordan and A. R. Ronald (ed.) Infectious diseases 5th ed. J. B. Lippincott Company Philadelphia Pa."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.2.602-604.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.2.602-604.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:16:11Z","timestamp":1645467371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.2.602-604.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1128\/AAC.48.2.602-604.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.2.602-604.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"2003-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}